Healthtronics — Investor Presentation (February 2007)
27 slides from Healthtronics's investor presentation, Feb 14, 2007
Slide 1: HealthTronics, Inc.
Exhibit 99.1 HealthTronics, Inc. February 2007
Slide 2: Forward-looking statements
Statements in this presentation that are not strictly historical, including statements regarding plans, objective and future financial performance, are “forward-looking” statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although
Slide 3: Introduction
Introduction Sam B. Humphries Became President and CEO of HealthTronics May, 2006 30 years in Medical Business GE AMS Venture Capital
Slide 4: HealthTronics
HEALTHTRONICS Based in Austin, Texas Public Company (NASDAQ: HTRN) World’s Largest Lithotripsy Service Provider Strong Profitable Partnership Model Access to Leading-Edge Technology Unique Business Relationship with One-Third of Urologists in the United States
Slide 5: Urology Services
Urology Services Map of US Sites
Slide 6: We spent last half of 2006 restructuring and refocusing our business
WE SPENT LAST HALF OF 2006 RESTRUCTURING AND REFOCUSING OUR BUSINESS Significant Reduction in Operating Expenses/Cost Exited Non-Strategic Businesses Sold Specialty Vehicle Business - $140M Entered New Strategic Segments One of Strongest Management Teams in the Business
Slide 7: HealthTronics Leadership Team
HEALTHTRONICS LEADERSHIP TEAM WORLD CLASS AND FOCUSED ON GROWTH (Organization Chart) Sam Humphries CEO James Whittenburg President Urology Services Ross Goolsby Chief Financial Officer Chris Schneider President Medical Products
Slide 8: Current Business Units
CURRENT BUSINESS UNITS Urology Services Lithotripsy Prostate Therapies Medical Products Products - - LithoDiamond ULTRA Lithotripter - - RevoLix Surgical Laser Service Maintenance Anatomical and Clinical Pathology
Slide 9: Key Strategies
KEY STRATEGIES Drive Growth and Profitability in our Core Lithotripsy Business Leverage the Power of our Business Relationship with One-Third of the Urologists in the United States We Are No Longer Just a Litho Company – We are a Premiere Urology Company Anything a Urologist Does Could be in Our Str
Slide 10: US Market for Urology Products
US MARKET FOR UROLOGY PRODUCTS (Chart) Category - 2005 Revenue (M) - Expected 5 Year CAGR Incontinence $610 8.6% BPH $240 11.8% Stone Management $230 6.4% Prostate Cancer $200 6.9% Scopes $190 6.6% ED $110 8.9% Access Products $60 8.0%
Slide 11: Strategic Adjacency Segments
STRATEGIC ADJACENCY SEGMENTS (Chart)
Slide 12: Stone Management-Lithotripsy Market
STONE MANAGEMENT-LITHOTRIPSY MARKET Total Market $230M Market - 6% CAGR 656K Procedures - 7% CAGR ESWL 387K Procedures - 2% CAGR Not Driven by Baby Boomers Multiple Treatment Methodologies ESWL Intracorpeal Lithotripsy Percutaneous Nephrolithotomy
Slide 13: Prostate Therapy - BPH
PROSTATE THERAPY - BPH Benign Prostatic Hyperplasia Non-Cancerous Enlargement of the Prostate Market Scope Affects 50% of Men Over Age 60 13M American Men in 2004 $650M - 12% CAGR Multiple Treatment Methodologies RevoLix Laser TUMT - Transurethral Microwave Therapy PVP GreenLight Surgery
Slide 14: Prostate Therapy - Prostate Cancer
PROSTATE THERAPY - PROSTATE CANCER Market Scope Second Most Common Cancer in American Males $5B Market 40M Males 230K New Cases Per Year 7% CAGR Dramatic Increase in Public Awareness Demanding Focal Therapy vs. Total Ablation Participating in the Diagnosis PSA Testing Anatomical Path Multi Treatment
Slide 15: Urology Services - Lithotripsy
UROLOGY SERVICES - LITHOTRIPSY Trusted Advisor to Urologist Partners Bring Value Added Products, Services and Benefits 62 Partnerships in 47 States ~130 Installed Lithotripsy Units ~3300 Physicians That Used HTRN Managed Devices During 2006 Unlimited Access to Technology
Slide 16: Medical Products
MEDICAL PRODUCTS Main Conduit for New Technologies Highest Growth Segments in Urology Manufacturing, Exclusive Distribution Products BPH – RevoLix Laser Lithotripsy – LithoDiamond ULTRA Services ClariPath Pathology Laboratory Maintenance Service
Slide 17: Medical Products
MEDICAL PRODUCTS US Installed Base: 190 HealthTronics Lithotripters 285 Lithotripters Under Maintenance (HealthTronics and Competitors) 22 RevoLix Lasers Pathology Lab Growing 10-15% Monthly
Slide 18: Two Key Questions
TWO KEY QUESTIONS How Will We Drive Growth? How Will We Drive Profitability?
Slide 19: Urology Services
UROLOGIY SERVICES Strategies to Drive Growth and Profitability WITHIN EXISTING PARTNERSHIPS NEW PARTNERSHIPS AND NEW PARTNERSHIP MODELS MARKET CONSOLIDATION
Slide 20: Within Existing Partnerships
WITHIN EXISTING PARTNERSHIPS Value Added Management Tools Unlimited Access to New Technologies Detailed Management of Utilization/Margins Drive Procedure Volume Marketing Low Cost Provider
Slide 21: New Partnerships and Models
NEW PARTNERSHIPS AND MODELS New Where Appropriate Competitive Partnerships New Technology - New Models RevoLix IMRT/IGRT
Slide 22: Market Consolidation
MARKET CONSOLIDATION HealthTronics Has 35% Market Share Nationwide Infrastructure Synergies Aggressive, Relentless But Disciplined
Slide 23: Medical Products
MEDICAL PRODUCTS Strategies to Drive Growth and Profitability Innovative Technology Service & Consumables ClariPath Pathology Lab
Slide 24: Medical Products
MEDICAL PRODUCTS Innovative Technology Launch of LithoDiamond Ultra Lithotripter “Game Changing” Equipment Dual Shock Source Expand RevoLix Laser Market Penetration - BPH Leading Edge Laser Technology Only System Providing Vaporization and Vaporesection Unequaled Physician Economic and Clinical Adva
Slide 25: Medical Products
MEDICAL PRODUCTS Services Expand Reach of our Pathology Laboratory - ClariPath Anatomical Pathology with Rapid Turn-Time and Exclusive Reporting Tools Provides Speed While Reducing Errors Project Doubling the Lab Size Within Six Months Expand Service Maintenance & Service Offering Only Service Organ
Slide 26: Financials
FINANCIALS Financial Impact of Restructuring Completed December, 2006 4Q Earnings to be Announced in Early March HealthTronics Has Not Provided Recent Guidance Strong Balance Sheet with Elimination of $120m of Long-Term Debt Strong Strategies in Place to Drive Growth and Productivity
Slide 27: HealthTronics, Inc.
HealthTronics, Inc. Feburary 2007 (Graphic of doctors)
HealthTronics — Investor Presentation (February 2007) on 6ix